Based on the above results, we validated the protein expression of FDX1 and DLAT in five matched normal and ccRCC clinical samples, and found that their protein expressions were poorly expressed in ccRCC tissues compared to adjacent tissues (Fig. 2D). This evidence concerns the gene FDX1 and nonpapillary renal cell carcinoma.